| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.26B | 1.17B | 1.09B | 1.44B | 1.32B | 721.40M |
| Gross Profit | 90.50M | 90.80M | 73.10M | 76.30M | 99.00M | 56.80M |
| EBITDA | 23.80M | 17.60M | 9.30M | 16.20M | 32.30M | 18.30M |
| Net Income | 4.40M | 3.20M | -8.40M | -600.00K | 16.90M | 7.60M |
Balance Sheet | ||||||
| Total Assets | 280.20M | 242.10M | 197.80M | 249.10M | 318.20M | 204.70M |
| Cash, Cash Equivalents and Short-Term Investments | 4.50M | 6.60M | 9.20M | 5.60M | 7.80M | 6.00M |
| Total Debt | 55.00M | 179.80M | 131.50M | 166.10M | 81.80M | 49.30M |
| Total Liabilities | 255.90M | 215.20M | 166.70M | 210.20M | 278.80M | 177.10M |
| Stockholders Equity | 24.30M | 26.90M | 31.10M | 38.90M | 39.40M | 27.60M |
Cash Flow | ||||||
| Free Cash Flow | 4.60M | 11.80M | 8.50M | 23.70M | -18.20M | 3.10M |
| Operating Cash Flow | 11.20M | 19.40M | 11.10M | 33.10M | -11.30M | 6.70M |
| Investing Cash Flow | -6.30M | -7.30M | -2.60M | 300.00K | -6.90M | 2.50M |
| Financing Cash Flow | -11.60M | -14.70M | -4.90M | -35.60M | 20.00M | -14.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £191.82M | 3.31 | 4.55% | 3.22% | -0.17% | -10.96% | |
70 Outperform | £2.80B | 10.60 | 23.83% | 3.44% | -15.99% | 69.97% | |
67 Neutral | £235.18M | -153.87 | 0.87% | ― | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £104.33M | 12.59 | 17.19% | 1.48% | 20.64% | ― | |
55 Neutral | £109.90M | 18.07 | 5.20% | 5.24% | 6.97% | -18.59% | |
51 Neutral | £164.51M | 47.38 | 5.23% | 2.38% | 5.93% | -18.20% |